ASCO Data Discussion - Research and Markets offers a brief of 'Genentech, Inc.' Conference Call.DUBLIN, Ireland -- The Genentech, Inc. (NYSE NYSE See: New York Stock Exchange :DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. ) Corporate Conference Call took place on 5-Jun-06 7:00pm ET. DNA reported that it is waiting to hear from FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for six submissions that it has put in over the last several months. The Co. introduced a new addition to the oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. senior management team, Dr. David Schenkein who will be the new head of clinical oncology and hematology. More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/90287 This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion